Ullah Atif, Ali Fawad, Ullah Farman, Sadozai Sajid Khan, Khan Saeed Ahmed, Hussain Sajid, Alrefaei Abdulwahed Fahad, Ali Sajid
Department of Pharmacy, Kohat University of Science and Technology, Kohat 26000, Pakistan.
Department of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh 2455, Saudi Arabia.
Pharmaceutics. 2025 Jan 17;17(1):125. doi: 10.3390/pharmaceutics17010125.
The development of resistance to traditional antifungal therapies has necessitated the exploration of alternative treatment strategies to effectively manage fungal infections, particularly those induced by (). This research investigates the possibility of integrating silver nanoparticles (AgNPs) with Terbinafine to improve antifungal effectiveness. Terbinafine, while potent, faces challenges with specific fungal strains, highlighting the need for strategies to enhance its treatment efficacy. Silver nanoparticles were produced through a light-activated, gelatin-based method, resulting in particle sizes ranging from 56.8 nm to 66.2 nm, confirmed by dynamic light scattering and scanning electron microscopy. Stability studies indicated that AgNPs produced with 30 mg of silver nitrate (AgNO₃) exhibited the greatest stability over 60 days across different temperature conditions. The analysis through UV-visible spectrophotometry revealed a notable shift in the absorption spectra as AgNO₃ concentrations increased, which was associated with a strengthening of plasmon resonance. The effectiveness of the AgNPs and Terbinafine combination was assessed against three strains of (ATCC 10231, ATCC 90028, and ATCC 18804). Terbinafine demonstrated strong antifungal properties with minimum inhibitory concentrations (MIC) values ranging from 2-4 µg/mL, whereas AgNPs on their own displayed moderate effectiveness. The integrated formulation notably enhanced effectiveness, especially against strain ATCC 90028, revealing a synergistic effect (FIFi = 0.369). These results were complemented by the findings of the time-to-kill assay, where the same strain showed a 3.2 log₁₀ CFU/mL decrease in viable cell count. The process by which AgNPs boost activity entails the disruption of the fungal cell membrane and its internal components, probably as a result of silver ion release and the generation of free radicals. The results indicate that the combination of Terbinafine and AgNPs may act as a powerful alternative for addressing resistant fungal infections, presenting an encouraging direction for future antifungal treatments.
对传统抗真菌疗法产生耐药性,使得有必要探索替代治疗策略,以有效控制真菌感染,尤其是由()引起的感染。本研究探讨了将银纳米颗粒(AgNPs)与特比萘芬整合以提高抗真菌效果的可能性。特比萘芬虽然有效,但对特定真菌菌株面临挑战,这凸显了提高其治疗效果的策略的必要性。通过光激活、基于明胶的方法制备了银纳米颗粒,通过动态光散射和扫描电子显微镜确认,其粒径范围为56.8纳米至66.2纳米。稳定性研究表明,用30毫克硝酸银(AgNO₃)制备的AgNPs在不同温度条件下60天内表现出最大稳定性。通过紫外可见分光光度法分析发现,随着AgNO₃浓度增加,吸收光谱发生显著变化,这与等离子体共振增强有关。评估了AgNPs与特比萘芬组合对三种(ATCC 10231、ATCC 90028和ATCC 18804)菌株的有效性。特比萘芬表现出很强的抗真菌特性,最低抑菌浓度(MIC)值范围为2 - 4微克/毫升,而单独的AgNPs显示出中等有效性。整合制剂显著提高了有效性,尤其是对ATCC 90028菌株,显示出协同效应(FIFi = 0.369)。这些结果得到了杀菌时间试验结果的补充,在该试验中,同一菌株的活菌数减少了3.2 log₁₀ CFU/毫升。AgNPs增强活性的过程涉及破坏真菌细胞膜及其内部成分,这可能是银离子释放和自由基产生的结果。结果表明,特比萘芬与AgNPs的组合可能作为解决耐药真菌感染的有力替代方案,为未来抗真菌治疗提供了一个令人鼓舞的方向。